Journal
JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE
Volume 54, Issue 1, Pages 45-63Publisher
KOREAN SOC PATHOLOGISTS
DOI: 10.4132/jptm.2019.11.05
Keywords
Meningioma; Molecular diagnosis; Pathological diagnosis
Categories
Ask authors/readers for more resources
Meningioma is the most common primary intracranial tumor in adults. The grading of meningioma is based on World Health Organization criteria, which rely on histopathological features alone. This grading system is unable to conclusively predict the clinical behavior of these tumors (i.e., recurrence or prognosis in benign or atypical grades). Advances in molecular techniques over the last decade that include genomic and epigenomic data associated with meningiomas have been used to identify genetic biomarkers that can predict tumor behavior. This review summarizes the molecular characteristics of meningioma using genetic and epigenetic biomarkers. Molecular alterations that can predict meningioma behavior may be integrated into the upcoming World Health Organization grading system.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available